Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 147 results.
User Information
Export Records
  1. 1.   Orphan G-Protein Coupled Receptor GPRC5B Is Critical for Lymphatic Development
  2. Xu, Wenjing; Nelson-Maney, Nathan P; Bálint, László; Kwon, Hyouk-Bum; Davis, Reema B; Dy, Danielle C M; Dunleavey, James M; St Croix,Brad; Caron, Kathleen M
  3. International Journal of Molecular Sciences. 2022, May 20; 23(10):
  1. 2.   Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors
  2. Kummar, Shivaani; Srivastava,Apurva; Navas, Tony; Cecchi, Fabiola; Lee, Young H.; Bottaro, Donald P.; Park, Sook Ryun; Do, Khanh T.; Jeong, Woondong; Johnson, Barry C.; Voth, Andrea R.; Rubinstein, Larry; Wright, John J.; Parchment,Ralph; Doroshow, James H.; Chen, Alice P.
  3. Investigational new drugs. 2021, Jun 28;
  1. 3.   Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFN gamma-Dependent Tumor Vessel Regression
  2. Kurebayashi, Yutaka; Olkowski,Colleen; Lane, Kelly C.; Vasalatiy, Olga V.; Xu, Biying C.; Okada, Ryuhei; Furusawa, Aki; Choyke, Peter L.; Kobayashi, Hisataka; Sato, Noriko
  3. Cancer Research. 2021, Jun 1; 81(11): 3092-3104.
  1. 4.   Potential of substituted quinazolines to interact with multiple targets in the treatment of cancer
  2. Choudhary, Shruti; Doshi, Arpit; Luckett-Chastain, Lerin; Ihnat, Michael; Hamel,Ernest; Mooberry, Susan L.; Gangjee, Aleem
  3. Bioogranic & Medicinal Chemistry. 2021, Apr 1; 35
  1. 5.   Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs
  2. Peach,Megan; Beedie, Shaunna L; Chau, Cindy H; Collins, Matthew K; Markolovic, Suzana; Luo, Weiming; Tweedie, David; Steinebach, Christian; Greig, Nigel H; Gütschow, Michael; Vargesson, Neil; Nicklaus,Marc; Figg, William D
  3. Molecules (Basel, Switzerland). 2020, DEC; 25(23): 5683.
  1. 6.   C-CBL is required for inhibition of angiogenesis through modulating JAK2/STAT3 activity in ROP development
  2. Chen, Shimei; Sun, Qiao; Sun, Dandan; Willette Brown,Jami; Anderson,Matthew; Gu, Qing; Lewandoski,Mark; Hu, Yinling; Zhu,Feng; Wei, Fang; Zhang, Jian
  3. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2020, DEC; 132: 110856.
  1. 7.   Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
  2. Hwang, Ilseon; Kim, Jeong Won; Ylaya, Kris; Chung, Eun Joo; Kitano, Haruhisa; Perry,Candice; Hanaoka, Jun; Fukuoka, Junya; Chung, Joon-Yong; Hewitt, Stephen M
  3. Journal of translational medicine. 2020, Nov 23; 18(1): 443.
  1. 8.   A novel patient-derived orthotopic xenograft (PDOX) mouse model of highly-aggressive liver metastasis for identification of candidate effective drug-combinations
  2. Zhang, Zhiying; Hu, Kaiwen; Miyake, Kentaro; Kiyuna, Tasuku; Oshiro, Hiromichi; Wangsiricharoen, Sintawat; Kawaguchi, Kei; Higuchi, Takashi; Razmjooei, Sahar; Miyake, Masuyo; Chawla, Sant P; Singh,Shree Ram; Hoffman, Robert M
  3. Scientific reports. 2020, Nov 18; 10(1): 20105.
  1. 9.   A divergent mode of activation of a nitrosyl iron complex with unusual antiangiogenic activity
  2. Carvalho, Edinilton Muniz; Ridnour,Lisa; Júnior, Florêncio Sousa Gouveia; Cabral, Pedro Henrique Bezerra; do Nascimento, Nilberto Robson Falcão; Wink, David A; Franco, Douglas W; de Medeiros, Mayara Jane Campos; de Lima Pontes, Daniel; Longhinotti, Elisane; de Freitas Paulo, Tércio; Bernardes-Génisson, Vania; Chauvin, Remi; Sousa, Eduardo Henrique Silva; Lopes, Luiz Gonzaga de França
  3. Journal of inorganic biochemistry. 2020, SEP; 210: 111133.
  1. 10.   Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome
  2. Henríquez, Soledad; Kohen, Paulina; Xu,Xia; Villarroel, Claudio; Muñoz, Alex; Godoy, Ana; Strauss, Jerome F; Devoto, Luigi
  3. Human reproduction (Oxford, England). 2020, JUL; 35(7): 1655-1665.
  1. 11.   Id1 and Id3 Maintain Steady-State Hematopoiesis by Promoting Sinusoidal Endothelial Cell Survival and Regeneration
  2. Gadomski,Stephen; Singh, Satyendra K.; Singh,Shweta; Sarkar,Tanmoy; Klarmann,Kim; Berenschot, Maximillian; Seaman,Steven; Jakubison,Brad; Gudmundsson,Kristbjorn; Lockett,Stephen; Keller,Jonathan
  3. Cell reports. 2020, Apr 28; 31(4):
  1. 12.   Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia
  2. Winn, Blake A; Devkota, Laxman; Kuch, Bunnarack; MacDonough, Matthew T; Strecker, Tracy E; Wang, Yifan; Shi, Zhe; Gerberich, Jeni L; Mondal, Deboprosad; Ramirez, Alejandro J; Hamel,Ernest; Chaplin, David J; Davis, Peter; Mason, Ralph P; Trawick, Mary Lynn; Pinney, Kevin G
  3. Journal of natural products. 2020, APR 24; 83(4): 937-954.
  1. 13.   TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer
  2. Peeney, David; Jensen, Sandra M; Castro, Nadia P; Kumar, Sarvesh; Noonan, Sylvia; Handler, Chenchen; Kuznetsov, Alex; Shih, Joanna; Tran, Andy D; Salomon,David; Stetler-Stevenson, William G
  3. Carcinogenesis. 2020, MAR; 41(3): 313-325.
  1. 14.   Pazopanib Inhibits Tumor Growth, Lymph-node Metastasis and Lymphangiogenesis of an Orthotopic Mouse of Colorectal Cancer
  2. Zhu, Guangwei; Zhao, Ming; Han, Qinghong; Tan, Yuying; Sun, Yu; Bouvet, Michael; Singh,Shree Ram; Ye, Jianxin; Hoffman, Robert M.
  3. Cancer genomics & proteomics. 2020, Mar-Apr; 17(2): 131-139.
  1. 15.   NO and hepatocellular cancer
  2. Wang, Ronghua; Geller, David A.; Wink,David; Cheng, Bin; Billiar, Timothy R.
  3. British journal of pharmacology. 2019, Dec 11;
  1. 16.   A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling
  2. Huang, Yujie; Fang, Jiansong; Lu, Weiqiang; Wang, Zihao; Wang, Qi; Hou, Yuan; Jiang, Xingwu; Reizes, Ofer; Lathia, Justin; Nussinov,Ruth; Eng, Charis; Cheng, Feixiong
  3. Cell chemical biology. 2019, Aug 15; 26(8): 1143-1158.e.
  1. 17.   The Distribution Volume of 18F-Albumin as a Potential Biomarker of Antiangiogenic Treatment Efficacy
  2. Roy, Jyoti; Kuo, Frank; Basuli, Falguni; Williams, Mark R; Wong, Karen; Green, Michael V; Seidel, Jurgen; Adler, Stephen S; Xu, Biying; Choyke, Peter L; Jagoda, Elaine M
  3. Cancer biotherapy & radiopharmaceuticals. 2019, May; 34(4): 238-244.
  1. 18.   Impairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves mTOR Malonylation
  2. Bruning, Ulrike; Morales-Rodriguez, Francisco; Kalucka, Joanna; Goveia, Jermaine; Taverna, Federico; Queiroz, Karla C S; Dubois, Charlotte; Cantelmo, Anna Rita; Chen, Rongyuan; Loroch, Stefan; Timmerman, Evy; Caixeta, Vanessa; Bloch, Katarzyna; Conradi, Lena-Christin; Treps, Lucas; Staes, An; Gevaert, Kris; Tee, Andrew; Dewerchin, Mieke; Semenkovich, Clay F; Impens, Francis; Schilling, Birgit; Verdin, Eric; Swinnen, Johannes V; Meier, Jordan; Kulkarni, Rhushikesh A; Sickmann, Albert; Ghesquière, Bart; Schoonjans, Luc; Li, Xuri; Mazzone, Massimiliano; Carmeliet, Peter
  3. Cell Metabolism. 2018, Dec 4; 28(6): 866-880.e15.
  1. 19.   Design, synthesis and preclinical evaluation of 5-methyl-N4-aryl-furo[2,3-d]pyrimidines as single agents with combination chemotherapy potential
  2. Devambatla, Ravi Kumar Vyas; Choudhary, Shruti; Ihnat, Michael; Hamel, Ernest; Mooberry, Susan L; Gangjee, Aleem
  3. Bioorganic & Medicinal Chemistry Letters. 2018, Oct 1; 28(18): 3085-3093.
  1. 20.   Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models
  2. Harris, Emily M; Strope, Jonathan D; Beedie, Shaunna L; Huang, Phoebe A; Goey, Andrew K L; Cook, Kristina M; Schofield, Christopher J; Chau, Cindy H; Cadelis, Melissa M; Copp, Brent R; Gustafson, Kirk; Figg, William D
  3. Marine Drugs. 2018, Jul 19; 16(7): pii: E241.
  1. 21.   Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release
  2. Szot, Christopher; Saha, Saurabh; Zhang, Xiaoyan M; Zhu, Zhongyu; Hilton, Mary; Morris, Karen; Seaman, Steven; Dunleavey, James; Hsu, Kuo-Sheng; Yu, Guo-Jun; Morris, Holly; Swing, Debbie; Haines, Diana C; Wang, Yanping; Hwang, Jennifer; Feng, Yang; Welsch, Dean; DeCrescenzo, Gary; Chaudhary, Amit; Zudaire, Enrique; Dimitrov, Dimiter S; St Croix, Brad
  3. The Journal of clinical investigation. 2018, Jul 2; 128(7): 2927-2943.
  1. 22.   PML: Regulation and multifaceted function beyond tumor suppression
  2. Hsu, Kuo-Sheng; Kao, Hung-Ying
  3. Cell and Bioscience. 2018, Jan 25; 8: 5.
  1. 23.   C/EBP-d positively regulates MDSC expansion and endothelial VEGFR2 expression in tumor development
  2. Min, Yongfen; Li, Jingdong; Qu, Peng; Lin, Charles
  3. Oncotarget. 2017, Aug 1; 8(31): 50582-50593.
  1. 24.   NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction
  2. Juhasz, Agnes; Markel, Susan; Gaur, Shikha; Liu, Han; Lu, Jiamo; Jiang, Guojian; Wu, Xiwei; Antony, Smitha; Wu, Yongzhong; Melillo, Giovanni; Meitzler, Jennifer L; Haines, Diana; Butcher, Donna; Roy, Krishnendu; Doroshow, James H
  3. Journal of Biological Chemistry. 2017, May 12; 292(19): 7866-7887.
  1. 25.   Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature
  2. Seaman, Steven; Zhu, Zhongyu; Saha, Saurabh; Zhang, Xiaoyan M; Yang, Mi Young; Hilton, Mary; Morris, Karen; Szot, Christopher; Morris, Holly; Swing, Debbie; Tessarollo, Lino; Smith, Sean W; Degrado, Sylvia; Borkin, Dmitry; Jain, Nareshkumar; Scheiermann, Julia; Feng, Yang; Wang, Yanping; Li, Jinyu; Welsch, Dean; DeCrescenzo, Gary; Chaudhary, Ritu; Zudaire, Enrique; Klarmann, Kimberly; Keller, Jonathan; Dimitrov, Dimiter; St Croix, Brad
  3. Cancer Cell. 2017, Apr 10; 31(4): 501-515.e8.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel